Evidence map›Paper›PMID 25002494›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Ras transformation uncouples the kinesin-coordinated cellular nutrient response.

Elma Zaganjor, Lauren M Weil, Joshua X Gonzales, John D Minna, Melanie H Cobb

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. KIF2A decreases IL-33 production and attenuates allergic asthmatic inflammation.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2022
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Elma ZaganjorDepartment of Pharmacology and.
Lauren M WeilDepartment of Pharmacology and.
Joshua X GonzalesDepartment of Pharmacology and.
John D MinnaDepartment of Pharmacology andHamon Cancer Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-9041.
Melanie H CobbDepartment of Pharmacology and melanie.cobb@utsouthwestern.edu.
The University of Texas Southwestern Medical Center · USSouthwestern Medical Center

Funding

UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI GIBBONS, DON LYNN · 1996 to 2024
$57.4M
Insulin-Regulated MAP Kinase PathwaysR37DK034128 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI COBB, MELANIE H. · 2007 to 2016
$5.1M
NCI NIH HHS P50 CA070907NCI NIH HHS P50CA70907NIDDK NIH HHS R37 DK034128NIDDK NIH HHS R37DK34128
6 · The paper itself

Abstract

The kinesin family members (KIFs) KIF2A and KIF2C depolymerize microtubules, unlike the majority of other kinesins, which transport cargo along microtubules. KIF2A regulates the localization of lysosomes in the cytoplasm, which assists in activation of the mechanistic target of rapamycin complex 1 (mTORC1) on the lysosomal surface. We find that the closely related kinesin KIF2C also influences lysosomal organization in immortalized human bronchial epithelial cells (HBECs). Expression of KIF2C and, to a lesser extent, KIF2A in untransformed and mutant K-Ras-transformed cells is regulated by ERK1/2. Prolonged inhibition of ERK1/2 activation with PD0325901 mimics nutrient deprivation by disrupting lysosome organization and decreasing mTORC1 activity in HBEC, suggesting a long-term mechanism for optimization of mTORC1 activity by ERK1/2. We tested the hypothesis that up-regulation of KIF2C and KIF2A by ERK1/2 caused aberrant lysosomal positioning and mTORC1 activity in a mutant K-Ras-dependent cancer and cancer model. In Ras-transformed cells, however, mTORC1 activity and lysosome organization appear independent of ERK1/2 and these kinesins although ERK1/2 activity and the kinesins are required for Ras-dependent proliferation and migration. We conclude that mutant K-Ras repurposes these signaling and regulatory proteins to support the transformed phenotype.

Indexed as

Amino AcidsAutophagyCell Line, TransformedCell Line, TumorCell Transformation, NeoplasticEpithelial CellsExtracellular Signal-Regulated MAP KinasesHumansKinesinsLysosomesMAP Kinase Signaling SystemMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesNeoplasmsPhosphorylationProtein TransportAmino AcidsExtracellular Signal-Regulated MAP KinasesKIF2A protein, humanKIF2C protein, humanKinesinsKRAS protein, humanMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesProto-Oncogene ProteinsProto-Oncogene Proteins p21(ras)ras ProteinsRibosomal Protein S6 KinasesRNA, Small InterferingTOR Serine-Threonine Kinases

Identifiers

PMID25002494
PMCPMC4115560
OpenAlexW2047030827

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.